发明名称 |
Modified caspase polypeptides and uses thereof |
摘要 |
The technology relates in part to compositions comprising modified Caspase-9 polypeptides, compositions comprising nucleic acids coding for modified Caspase-9 polypeptides, chimeric modified Caspase-9 polypeptides, and methods of use thereof, including methods for cell therapy. Methods for cell therapy include modifying transfused cells to express an inducible modified Caspase-9 protein, with reduced basal activity in the absence of the inducer. |
申请公布号 |
US9434935(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201313792135 |
申请日期 |
2013.03.10 |
申请人 |
BELLICUM PHARMACEUTICALS, INC. |
发明人 |
Spencer David;Chang Wei-Chun |
分类号 |
C07H21/04;C12N15/00;C12N15/63;C12N9/64;A61K31/4545;A01K67/00 |
主分类号 |
C07H21/04 |
代理机构 |
Grant IP, Inc. |
代理人 |
Grant IP, Inc. |
主权项 |
1. A composition comprising a nucleic acid comprising a nucleotide sequence that encodes a chimeric protein comprising a FKBP multimeric ligand binding region and a modified Caspase-9 polypeptide, wherein the modified Caspase-9 polypeptide comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 9, and comprises the amino acid substitution N405Q, wherein
a) the chimeric protein has a basal activity less than 50% of the basal activity of a chimeric protein comprising a FKBP multimeric ligand binding region and a Caspase-9 polypeptide lacking the caspase recruitment domain (CARD) and having the amino acid sequence of SEQ ID NO: 9; and b) Caspase-9 activity is induced upon binding of a ligand to the FKBP multimeric ligand binding region of the chimeric protein. |
地址 |
Houston TX US |